|
| Recipient sex | PGD-HLA donor sex and Dxa | Patient origin | Affected sibling thalassemia mutation diagnosis | HSC source | Recipient age at HSCT (months) | HSCT status/country HSCT performed | HSCT-related complications |
|
1 | M | M (normal) | Thailand | BThal/HbE Cd.17 (A>T)/HbE | UCB | 59 | Success/Thailand | None |
2 | F | F (HbE trait) | Thailand | BThal/HbE HbE/IVSII-654 (C>T) | UCB | 45 | Success/Thailand | None |
3 | F | M (HbE trait) | Thailand | BThal/HbE Cd.41/42 (-TCTT)/HbE | UCB | 67 | Success/Thailand | None |
4 | M | F (HbE trait) | Thailand | BThal/HbE Cd.41/42 (-TCTT)/HbE | UCB | 39 | Success/Thailand | None |
5 | M | F/F (IVSI-5) | Thailand | BThal/HbE HbE/IVSI-5 (G>C) | UCB twins | 56 | Success/Thailand | Mild VOD, completely resolved |
6 | F | F (normal) | Thailand | homoB-thal IVSII-654 (C>T)/Cd.41/42 (-TCTT) | UCB | 45 | Success Thailand | None |
7 | M | M (Beta-28) | Thailand | homoB-thal beta-28 (A>G)/Cd.17 (A>T) | UCB in/ex utero collection | 36 | Success/Thailand | None |
8 | F | F (HbE trait) | Thailand | B-thal/HbE HbE/IVSII-654 (C>T) | UCB + BMc (BM donor age 76 months) | 202 | Success/Thailand | Grade 2 acute GvHD currently regress on cyclosporine and prednisolone. Mild VOD, thrombocytopenia, and CMV reactivation, all completely resolved |
9 | F | M (normal) | Cambodia | B-thal/HbE HbE/Cd.17 (A>T) | BMc (BM donor age 12 months) (UCB not used) | 132 | Success/India | None |
10 | M | F (normal) | Cambodia | B-thal/HbE HbE/IVSII-654 (C>T) | UCB | Awaiting HSCT |
11 | F | M (normal) | China | homoB-thal beta-28/Cd.41/42 (-TCTT) | UCB + BMc (BM donor age 36 months) | 108 | Success/China | None |
12 | F | M (normal) | India | homoB-thal IVSI-5 (G>C)/IVSI-1 (G>A) | UCB | 60 | Success/India | None |
13 | M | M (carrier) | India | homoB-thal IVSI-5 (G>C)/IVSI-5 (G>C) | N/Ab | Unknown |
14 | F | M (IVSI-5) | India | homoB-thal Cd.41/42 (TCTT)/IVSI-5 (G>C) | UCB + BMc (BM donor age at 29 months) | 75 | Success/Thailand | None |
15 | F | F (αα/--SEA) | Vietnam | HbH-CS disease (--/αCsα) | UCB | Awaiting HSCT |
|